Phase 4 Dermatitis Clinical Trials
10 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–10 of 10 trials
Recruiting
Phase 4
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Sleep DisturbanceAtopic Dermatitis
Northwestern University40 enrolled1 locationNCT05042258
Recruiting
Phase 4
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Atopic Dermatitis
Johns Hopkins University30 enrolled1 locationNCT06116526
Recruiting
Phase 4
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
Atopic Dermatitis
Eli Lilly and Company200 enrolled66 locationsNCT07006792
Recruiting
Phase 4
Efficacy and Safety of Weekend Topical Mild Corticosteroid Therapy for Maintenance of Seborrheic Dermatitis: A Randomized Controlled Trial
Seborrheic Dermatitis
Dr Imdad ullah khan, dermatology ward, khyber teaching hospital, peshawar61 enrolled1 locationACTRN12625001406493
Recruiting
Phase 4
Ethnic Differences in Mechanisms of Action of Dupilumab
Atopic Dermatitis
University of Michigan30 enrolled1 locationNCT05268107
Recruiting
Phase 4
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
atopic dermatitis (eczema)Atopic Dermatitis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)216 enrolled2 locationsNCT06004986
Recruiting
Phase 4
Lebrikizumab in Moderate-to-severe Atopic Dermatitis
Atopic Dermatitis
Johann E Gudjonsson MD PhD48 enrolled4 locationsNCT06906497
Recruiting
Phase 4
Molecular Signatures of Cutaneous Dupilumab Response
Atopic Dermatitis
University of California, San Francisco15 enrolled1 locationNCT05858619
Recruiting
Phase 4
Dupixent and Narrowband UVB for Atopic Dermatitis
Atopic Dermatitis
Psoriasis Treatment Center of Central New Jersey40 enrolled1 locationNCT05285839
Not Yet Recruiting
Phase 4
Assessing the effectiveness of ENDOR combination therapy in atopic dermatitis (eczema) and psoriasis patients
atopic dermatitis (eczema)
GNP Australia60 enrolled1 locationACTRN12619001536156